In this study investigating the CSF in PD–DLB and control subjects, CD4+ T cells in diseased subjects were detected to have a transcriptionally altered immune cell subtype, as defined by higher expression of the cd69 gene, an early activation marker on T cells, and of the chemokine receptor CXCR4 [50]. This evidence concerns the gene CD4 and Parkinson disease.